SCHEMBL4864426

SCHEMBL4864426

O=CN(O)C(C(=O)NNc1nccc(C(F)(F)F)n1)C1CCCCCC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.42
PRMT5 O14744 1/20 0.38
WDR77 Q9BQA1 1/20 0.38
HDAC8 Q9BY41 1/20 0.37
TAS2R14 Q9NYV8 1/20 0.36
SYK P43405 8/20 0.36
ALDH1A1 P00352 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
IDH1 O75874 1/20 0.35
IDH2 P48735 1/20 0.35
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34
ACKR3 P25106 1/20 0.34
MAPT P10636 1/20 0.33
CYP2D6 P10635 1/20 0.33
DPP4 P27487 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
DPP7 Q9UHL4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4870852 1.00 GAA (0.42) GAAPRMT5WDR77HDAC8TAS2R14
SCHEMBL4868014 0.99 GAA (0.43) GAAPRMT5WDR77HDAC8TAS2R14
SCHEMBL4864629 0.90 GAA (0.41) GAAPRMT5WDR77HDAC8TAS2R14
SCHEMBL4864288 0.89 GAA (0.40) GAAPRMT5WDR77HDAC8TAS2R14
SCHEMBL6241915 0.88 GAA (0.39) GAAPRMT5WDR77HDAC8TAS2R14
SCHEMBL4872289 0.88 GAA (0.39) GAAPRMT5WDR77HDAC8TAS2R14
SCHEMBL4870936 0.86 GAA (0.41) GAAPRMT5WDR77HDAC8TAS2R14
SCHEMBL4867317 0.85 HTT (0.40) SYKALDH1A1NPSR1
SCHEMBL1596253 0.83 GAA (0.39) GAAPRMT5WDR77HDAC8TAS2R14
SCHEMBL1596116 0.83 GAA (0.39) GAAPRMT5WDR77HDAC8TAS2R14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7332485-B2 Peptide deformylase inhibitors SMITHKLINE BEECHAM CORP (US) 2008-02-19 US claimed
US-20060160802-A1 Peptide deformylase inhibitors GLAXO GROUP LIMITED 2006-07-20 US claimed
US-7332485-B2 Peptide deformylase inhibitors SMITHKLINE BEECHAM CORP (US) 2008-02-19 US disclosed
US-20060160802-A1 Peptide deformylase inhibitors GLAXO GROUP LIMITED 2006-07-20 US disclosed
WO-2005005456-A2 PEPTIDE DEFORMYLASE INHIBITORS GLAXO GROUP LIMITED (GB) 2005-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160802-A1 Peptide deformylase inhibitors PDF, PEPD, DPEP1 GAA 1043/4885PRMT5 985/4885WDR77 1123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.